Search

everythinglearnresearchcommunity

for

Search:↓

The research suggests immune system changes and specific gene expression may contribute to male hair loss, proposing potential new treatments.

Adolescents with hair loss show different hormone levels by sex and often have related metabolic issues.

Both minoxidil-spironolactone and minoxidil-finasteride treatments work for hair loss, but minoxidil-spironolactone is slightly more effective, especially in women.

Combining platelet-rich plasma with other treatments may improve hair growth in people with hair loss, but more research is needed.

Cellcurin therapy with microneedling increases hair density and thickness in treating hair loss in men and women.

More personalized and effective treatments for androgenetic alopecia are needed.

Women with PCOS and hair loss have lower levels of the protein gelsolin in their blood.

Systemic mastocytosis may cause a type of hair loss called cicatricial alopecia.

Male hair loss is mainly due to thinner hair, not less hair.

Hair loss can be caused by hormones and genetics.

Androgenetic alopecia is the most common cause of hair loss, affecting both men and women, with varying patterns and prevalence among different races.

Androgenetic alopecia, or common baldness, is the main cause of hair loss in men due to shrinking hair follicles from hormones, and it's normal but can be a problem if it's too much or too early.

Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.

Dermatologists should be aware of and manage alopecia risks from certain cosmetic procedures.

Trichoscopy helps tell apart other hair loss conditions from common hair loss.

Increased awareness and research are needed to prevent hair loss from cosmetic procedures.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

Hair loss common in Australia; men affected earlier, more often than Asians; women less concerned.

Hair loss can significantly affect a person's self-esteem and body image, especially in young people, those who value their looks highly, and women.

5% minoxidil helps hair regrowth in androgenic alopecia.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Substance from human umbilical cord blood cells promotes hair growth.

Aromatase inhibitors cause male pattern hair loss in women.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

Combination therapies for androgenetic alopecia work best but can have significant side effects and costs.

Many dermatologists in Saudi Arabia recommend vitamins and minerals for hair loss, often based on personal experience rather than strong evidence.

The document concludes that early diagnosis is key for treating common baldness in women, but reassurance is often the best approach as hair thinning can be a normal part of aging.

The article concludes that different types of hair loss require specific treatments and psychological support is important.

15.33% of young Caucasian men have severe hair loss, with higher rates in Jewish men and links to age, BMI, and possibly metabolic syndrome.